<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="other" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">ijeph</journal-id>
			<journal-title-group>
				<journal-title>Interdisciplinary Journal of Epidemiology and Public Health</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Interdiscipl. J. Epidemiol. Public Health</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">2665-427X</issn>
			<publisher>
				<publisher-name>Facultad Ciencias de la Salud, Universidad Libre</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.18041/2665-427X/ijeph.2.6230</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Experiences</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>COVID-19: Perspective, what we know and learn</article-title>
				<trans-title-group xml:lang="es">
					<trans-title>COVID-19: Perspectiva, lo que sabemos y lo que aprendemos</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Galvis Pedraza</surname>
						<given-names>Maryory</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="original">Institute of Genetic Medicine Dr. Carolina Isaza SAS. Cali, Colombia </institution>
				<institution content-type="orgname">Institute of Genetic Medicine Dr. Carolina Isaza SAS</institution>
				<addr-line>
					<city>Cali</city>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="original"> Secretaria de Salud Publica, Cali, Colombia</institution>
				<institution content-type="orgname">Secretaria de Salud Publica</institution>
				<addr-line>
					<city>Cali</city>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<label>Correspondencia</label>Maryory Galvis Pedraza. Email: <email>maryo.galvis92@outlook.com</email>
				</corresp>
			</author-notes>
			<pub-date date-type="pub" publication-format="electronic">
				<day>05</day>
				<month>05</month>
				<year>2020</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">
				<season>Jan-Jun</season>
				<year>2020</year>
			</pub-date>
			<volume>3</volume>
			<issue>1</issue>
			<elocation-id>e-6230</elocation-id>
			<history>
				<date date-type="received">
					<day>10</day>
					<month>04</month>
					<year>2020</year>
				</date>
				<date date-type="accepted">
					<day>25</day>
					<month>04</month>
					<year>2020</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<kwd-group xml:lang="es">
				<title>Keywords:</title>
				<kwd>COVID-19</kwd>
				<kwd>Coronavirus</kwd>
				<kwd>perspective</kwd>
				<kwd>epidemiology</kwd>
				<kwd>experiences</kwd>
			</kwd-group>
			<counts>
				<fig-count count="0"/>
				<table-count count="0"/>
				<equation-count count="0"/>
				<ref-count count="15"/>
				<page-count count="0"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<p> Year 2020 made its debut with tension and uncertainty. For years, nations have invested in defense, politics, space and technology careers. Gadgets for making a bridge between humanity and the artificial have eclipsed, in their attractive catwalk, the gravity of consumerism and selfishness, to the detriment of the natural world that withers in a race against time. COVID-19 put a real stop to humanity, in the case of the respiratory infection caused by SARS-Cov-2 <xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. It is a disease that slowly began to spread around the world, emerging only four months ago in China. China warned about the seriousness of the infection and its potential for expansion, generously deploying severe sanitary measures such as the construction of buildings dedicated to the exclusive health care of those who suffered it and militarily demanding the isolation of its people <xref ref-type="bibr" rid="B2"><sup>2</sup></xref>. The world remained expectant, innocent and indifferent. The fallacy of the hypothesis that what does not touch us will nor hurt us. Commercial flights, land and sea terminals remained open. The calls of compatriots were answered to return them home, in a so-called &quot;humanitarian rescue.&quot; Others candidly returned to their respective countries and regions to become index patient candidates.</p>
		<p>As epidemiologists, we began to make personal bets and have discussions by way of speculation, doing academic exercises about the situation that we saw in front of us, deeply rooted in the culture of what does not touch us. The truth is that we do not defend a conviction of this generation: there are no limits. And what a lesson, that the Earth is indeed only one, and even the smallest of things (a virus) can make the most significant of differences (pandemic).</p>
		<p>Scientists around the world did not take long to express themselves, from all the perspectives in which the knowledge gap in the face of the new virus could be addressed. Even so, the position that Covid-19 has put us in is well known to us. The novelty is that it had not been previously presented to our immune system. Due to the advances in molecular biology, just two weeks after its discovery, we knew its genetic makeup <xref ref-type="bibr" rid="B3"><sup>3</sup></xref>. On the other hand, epidemiology is a professional exercise where observation is refined and which allows us to expose the evidence supported from the logic and mathematics of a situation, approaching its origin, daring to model the course of a story and anticipating what will be its outcome, teaching us to learn from the past in order to infer about the future.</p>
		<p>Other microorganisms have threatened and decimated humanity throughout our history. In the last two decades and also originating in China, SARS (2003) and MERS (2012) <xref ref-type="bibr" rid="B4"><sup>4</sup></xref> emerged. International agreements to combat them were probably lax at that time, giving rise to our present. HIV, which the world no longer fears, and Ebola, whose fatality has not allowed it to leave Africa, are obligatory examples. Other outbreaks that are not so deadly, but which have demonstrated the fragility of our human condition, include those that occurred in Latin America with Chikungunya (2014) and Zika (2015) <xref ref-type="bibr" rid="B5"><sup>5</sup></xref>. All of these examples attest that we live in a constant battle. Did we learn to control them? Why does dengue continue to claim victims locally? Malaria and tuberculosis that affect large populations in &quot;any&quot; corner of the world, are still active.</p>
		<p>From epidemiology, we know that to contain an epidemic, the mobility of the susceptible population must be limited. In this case, isolation is assumed for &quot;everyone&quot;, and cases must be dealt with until resolution, which is an apparently simple formula. It seems, however, that amid indifference from some and ignorance in others, many individuals out of freedom, vanity, need or selfishness undertook intercontinental trips. The sick began to be seen, with the first case in neighboring countries to China before the end of January and then hundreds of cases in Spain, Italy, France, Germany, Canada and the United States <xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref>, and soon in others countries distant from the place of origin. Multiple studies have been raised against Covid-19 in all branches of science <xref ref-type="bibr" rid="B8"><sup>8</sup></xref>, from the presentation of case reports, to cohorts of thousands of patients who have suffered it, revealing the common symptoms of the disease: fever, cough, shortness of breath, myalgia, lethargy <xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. Allowing quickly the generation of protocols and methodologies in the intervention from suspicious asymptomatic cases to the management of patients in the ICU.</p>
		<p>Given the lack of and end to this event, every minute counts and all questions are important, even those that do not generate results, because in science we allow ourselves to be a result too. The truth is that we are learning: theory is enough, but nobody expected the challenge of putting it into practice. National guidelines are limited at being successful in controlling this pandemic. Even more so when the national guidelines and health professionals did not have the necessary practical knowledge, only intuition and a lot of theoretical knowledge.</p>
		<p>Studies were generated where the possibility of acquiring the disease on an airplane trip was demonstrated. No evidence was found, determined by a p-value, that infected passengers were the first contact of patients who eventually tested positive when sharing a one-hour flight, but they did find a relationship for those who shared it for three hours <xref ref-type="bibr" rid="B10"><sup>10</sup></xref>. Then the question arises: were the common contact elements such as doors, handrails, fomites, the transmission vehicles on this flight, or in a clinic? Are shared spaces such as the office or a public event important for transmission? And if so, how long does the virus stay active there? All this led to the determination of the hours and the kinetic curve in the decrease of viral particles given a concentration, a surface (glass, plastic, cardboard, etc.) and environmental conditions. From these questions, information began to be generated that today, after four months, help in making decisions to control the pandemic. Important debates between scientific societies and experts have arrived at positions regarding the use of masks, as we know that the virus can also be transmitted by aerosols, denying the theory without argument that the viral particle falls to the ground once it is outside the host <xref ref-type="bibr" rid="B11"><sup>11</sup></xref>.</p>
		<p>Epidemiologists, having evaluated all the possible circumstances, ask themselves the question of how to protect the susceptible population. This virus is characterized by its omnipresence and its contagion capacity, but it is ironic that, despite all these drawbacks, the nature of the virus allows it to be eliminated by contact with such trivial and common elements as soap and water. This is one of the main strategies for its control: isolation and hand washing.</p>
		<p>In order to mitigate the impact and prolongation of this infection, the exponential growth in the spread was studied, comparing it with past epidemics. Thus modeling the curves showing what the behavior of the disease would be in terms of its transmission capacity, mortality and the recovery rate, all of which depends on the size of the population and on the risk factors such as chronic or autoimmune diseases that are previously present the patient. Age <xref ref-type="bibr" rid="B12"><sup>12</sup></xref> and being diabetic or specifically hypertensive <xref ref-type="bibr" rid="B13"><sup>13</sup></xref>, have been shown to be a determining factor for the prognosis regarding what the course of the disease will be in a specific population. There is still no treatment that is safely implemented and is expected to recover the health of the patient; chloroquine and hydroxychloroquine are candidates, with results that are hardly satisfactory on the clearance of viremia <xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref> among the multiple therapeutic resources.</p>
		<p>To reach a true inflection point, without speculation, or delaying the expectations of citizens who do not have to be experts on the subject, we must reach a collective commitment regarding social distancing, disinfection habits and many changes in their lives. It is necessary to have information that reliably declares what is the real magnitude of the cases of infection and the population at risk, for example in which sectors of the cities you are at greater risk. Details that accurately quantify mortality and recovered patients allow more accurate projections to be made, allowing more accurate health measures to be taken. This helps to quantify how many beds, how many of them are intensive care units, how many tests and how much talent in healthcare it takes to be victorious in this battle against a microorganism that we already know and that we now need to slow down and smooth the curve in the Gaussian bell <xref ref-type="bibr" rid="B15"><sup>15</sup></xref>. This is our challenge. Prolonging this top of the curve enough so that future vaccines will allow us to implement an immunization strategy, so that this pandemic ends, leaving behind just another chapter in our history.</p>
		<p>Applauding the good will and professionalism of those who work for the health of Colombians every day, I must admit that there is a lack of public policies around contingency for events like this, in addition to a more effective organizational system. From my experience, it is regrettable that epidemiological health surveillance becomes a whole “gymkhana” in terms of locating a patient and following up on him. Applications have been emerging from technology that enable solutions to these problems. This means that if the political will exists, many health and social problems can be solved.</p>
		<p>It is sad to be a spectator when some productive sectors - despite warnings from academia - make decisions that put the health of a sector of society at risk, but workers need wages to survive. It is a reality for many Colombians that if you do not work you may not get sick from Covid, but you still &quot;need&quot; to support your family and so it is not an option not to work. The lesson that this experience leaves us is that academics must have a more decisive position on health issues and participate from an equal position as decision makers from other sectors including political and economic. In addition, the request is clear: a real change in health policies is needed.</p>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Morens DM, Daszak P, Taubenberger JK. Escaping pandora´s box- another novel Coronavirus. N Engl J Med. 2020; 382: 1293-1295. Doi: 10.1056/NEJMp2002106</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Morens</surname>
							<given-names>DM</given-names>
						</name>
						<name>
							<surname>Daszak</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Taubenberger</surname>
							<given-names>JK</given-names>
						</name>
					</person-group>
					<article-title>Escaping pandora´s box- another novel Coronavirus</article-title>
					<source>N Engl J Med</source>
					<year>2020</year>
					<volume>382</volume>
					<fpage>1293</fpage>
					<lpage>1295</lpage>
					<pub-id pub-id-type="doi">10.1056/NEJMp2002106</pub-id>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Phua J, Weng L, Ling L, Egi M, Lim C, Divatia JV, et al. Review Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir. 2020;2019(20): 1-12. doi: 10.1016/S2213-2600(20)30161-2.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Phua</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Weng</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Ling</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Egi</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Lim</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Divatia</surname>
							<given-names>JV</given-names>
						</name>
					</person-group>
					<article-title>Review Intensive care management of coronavirus disease 2019 (COVID-19) challenges and recommendations</article-title>
					<source>Lancet Respir</source>
					<year>2020</year>
					<volume>2019</volume>
					<issue>20</issue>
					<fpage>1</fpage>
					<lpage>12</lpage>
					<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30161-2</pub-id>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224): 565-74. doi: 10.1016/S0140-6736(20)30251-8.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lu</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Zhao</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Niu</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Yang</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Wu</surname>
							<given-names>H</given-names>
						</name>
					</person-group>
					<article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus implications for virus origins and receptor binding</article-title>
					<source>Lancet</source>
					<year>2020</year>
					<volume>395</volume>
					<issue>10224</issue>
					<fpage>565</fpage>
					<lpage>574</lpage>
					<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30251-8</pub-id>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Fauci AS, Lane HC, Redfield RR. Covid-19 - Navigating the Uncharted. N Engl J Med 2020; 382:1268-1269. DOI: 10.1056/NEJMe2002387</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Fauci</surname>
							<given-names>AS</given-names>
						</name>
						<name>
							<surname>Lane</surname>
							<given-names>HC</given-names>
						</name>
						<name>
							<surname>Redfield</surname>
							<given-names>RR</given-names>
						</name>
					</person-group>
					<article-title>Covid-19 - Navigating the Uncharted</article-title>
					<source>N Engl J Med</source>
					<year>2020</year>
					<volume>382</volume>
					<fpage>1268</fpage>
					<lpage>1269</lpage>
					<pub-id pub-id-type="doi">10.1056/NEJMe2002387</pub-id>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Bulut T.New Epidemiological Model Suggestions Revealing Size of Epidemics Based on the COVID-19 Pandemic Example: Wavelength Models. 2020; pre-print. Doi:10.1101/2020.04.07.20056432</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Bulut</surname>
							<given-names>T</given-names>
						</name>
					</person-group>
					<source>New Epidemiological Model Suggestions Revealing Size of Epidemics Based on the COVID-19 Pandemic Example: Wavelength Models</source>
					<year>2020</year>
					<pub-id pub-id-type="doi">10.1101/2020.04.07.20056432</pub-id>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020; 382: 929-936 DOI: 10.1056/NEJMoa2001191.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lofy</surname>
							<given-names>KH</given-names>
						</name>
						<name>
							<surname>Wiesman</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Bruce</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Spitters</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Ericson</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Wilkerson</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>First Case of 2019 Novel Coronavirus in the United States</article-title>
					<source>N Engl J Med</source>
					<year>2020</year>
					<volume>382</volume>
					<fpage>929</fpage>
					<lpage>936</lpage>
					<pub-id pub-id-type="doi">10.1056/NEJMoa2001191</pub-id>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Rothe R, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020; 382:970-971DOI: 10.1056/NEJMc2001468.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rothe</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Schunk</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Sothmann</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Bretzel</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Froeschl</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Wallrauch</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Transmission of 2019-nCoV infection from an asymptomatic contact in Germany</collab>
					</person-group>
					<article-title>N Engl</article-title>
					<source>J Med</source>
					<year>2020</year>
					<volume>382</volume>
					<fpage>970</fpage>
					<lpage>971DOI</lpage>
					<pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Perlman S. Another Decade, Another Coronavirus. N Engl J Med 2020; 382:760-762DOI: 10.1056/NEJMe2001126.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Perlman</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Another Decade, Another Coronavirus</article-title>
					<source>N Engl J Med</source>
					<year>2020</year>
					<volume>382</volume>
					<fpage>760</fpage>
					<lpage>762DOI</lpage>
					<pub-id pub-id-type="doi">10.1056/NEJMe2001126</pub-id>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-13. doi: 10.1016/S0140-6736(20)30211-7.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Chen</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Zhou</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Dong</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Qu</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Gong</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Han</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China a descriptive study</article-title>
					<source>Lancet</source>
					<year>2020</year>
					<volume>395</volume>
					<issue>10223</issue>
					<fpage>507</fpage>
					<lpage>513</lpage>
					<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Olsen SJ, Chang HL, Cheung TY, Tang AF, Fisk TL, Ooi SP. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med. 2003; 349(25): 2416-22</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Olsen</surname>
							<given-names>SJ</given-names>
						</name>
						<name>
							<surname>Chang</surname>
							<given-names>HL</given-names>
						</name>
						<name>
							<surname>Cheung</surname>
							<given-names>TY</given-names>
						</name>
						<name>
							<surname>Tang</surname>
							<given-names>AF</given-names>
						</name>
						<name>
							<surname>Fisk</surname>
							<given-names>TL</given-names>
						</name>
						<name>
							<surname>Ooi</surname>
							<given-names>SP</given-names>
						</name>
					</person-group>
					<article-title>Transmission of the severe acute respiratory syndrome on aircraft</article-title>
					<source>N Engl J Med</source>
					<year>2003</year>
					<volume>349</volume>
					<issue>25</issue>
					<fpage>2416</fpage>
					<lpage>2422</lpage>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020; 382(16): 1564-1567. doi: 10.1056/NEJMc2004973.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>van Doremalen</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Bushmaker</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Morris</surname>
							<given-names>DH</given-names>
						</name>
						<name>
							<surname>Holbrook</surname>
							<given-names>MG</given-names>
						</name>
						<name>
							<surname>Gamble</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Williamson</surname>
							<given-names>BN</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1</article-title>
					<source>N Engl J Med.</source>
					<year>2020</year>
					<volume>382</volume>
					<issue>16</issue>
					<fpage>1564</fpage>
					<lpage>1567</lpage>
					<pub-id pub-id-type="doi">10.1056/NEJMc2004973</pub-id>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Yuan H-Y, Mao A, Han G, Yuan H, Pfeiffer D. Effectiveness of quarantine measure on transmission dynamics of COVID-19 in Hong Kong. 2020; pre-print. Doi: 10.1101/2020.04.09.20059006</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Yuan</surname>
							<given-names>H-Y</given-names>
						</name>
						<name>
							<surname>Mao</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Han</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Yuan</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Pfeiffer</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<source>Effectiveness of quarantine measure on transmission dynamics of COVID-19 in Hong Kong</source>
					<year>2020</year>
					<pub-id pub-id-type="doi">10.1101/2020.04.09.20059006</pub-id>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Zeng Z, Sha T, Zhang Y, Wu F, Hu H, Li H, et al. Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study. 2020; doi:10.1101/2020.04.06.20054825</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zeng</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Sha</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Zhang</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Wu</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Hu</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>H</given-names>
						</name>
					</person-group>
					<article-title>Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study</article-title>
					<year>2020</year>
					<volume>doi</volume>
					<fpage>10</fpage>
					<lpage>10</lpage>
					<pub-id pub-id-type="doi">10.1101/2020.04.06.20054825</pub-id>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome main point: hydroxychloroquine was found to be more potent than chloroquine at inhibiting SARS-CoV-2 in vit. 2. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa237.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Yao</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Ye</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Zhang</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Cui</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Huang</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Niu</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome main point hydroxychloroquine was found to be more potent than chloroquine at inhibiting SARS-CoV-2 in vit. 2</article-title>
					<source>Clin Infect Dis</source>
					<year>2020</year>
					<pub-id pub-id-type="doi">10.1093/cid/ciaa237</pub-id>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Lee T-W, Park JE, Hung D. Gaussian Statistics and Data-Assimilated Model of Mortality due to COVID-19 : China , USA , Italy , Spain , UK , Iran , and the World Total. 2020; doi:10.1101/2020.04.06.20055640. Pre-print</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Lee</surname>
							<given-names>T-W</given-names>
						</name>
						<name>
							<surname>Park</surname>
							<given-names>JE</given-names>
						</name>
						<name>
							<surname>Hung</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<source>Gaussian Statistics and Data-Assimilated Model of Mortality due to COVID-19 : China , USA , Italy , Spain , UK , Iran , and the World Total</source>
					<year>2020</year>
					<pub-id pub-id-type="doi">10.1101/2020.04.06.20055640</pub-id>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<title>Notas:</title>
			<fn fn-type="other" id="fn1">
				<label>Citación</label>
				<p><bold>:</bold> Galvis PM. COVID-19: Perspective, what we know and learn. IJEPH. 2020; 3(1): e-6230 Doi: 10.18041/2665- 427X/ijeph.1.6230</p>
			</fn>
		</fn-group>
	</back>
</article>